Abacavir Sulfate (Major Pharmaceuticals)
Welcome to the PulseAid listing for the Abacavir Sulfate drug offered from Major Pharmaceuticals. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Major Pharmaceuticals |
NON-PROPRIETARY NAME: | Abacavir Sulfate |
SUBSTANCE NAME: | ABACAVIR SULFATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2012-12-17 |
END MARKETING DATE: | 0000-00-00 |
Abacavir Sulfate HUMAN PRESCRIPTION DRUG Details:
Item Description | Abacavir Sulfate from Major Pharmaceuticals |
LABELER NAME: | Major Pharmaceuticals |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 300(mg/1) |
START MARKETING DATE: | 2012-12-17 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0904-6523_35267d2b-9a97-43d6-a7e7-1cb47ea009df |
PRODUCT NDC: | 0904-6523 |
APPLICATION NUMBER: | ANDA201570 |
Other ABACAVIR SULFATE Pharmaceutical Manufacturers / Labelers: